Last update April 16, 2015
Very Low Risk
Excreted into breast milk in a clinically non-significant amount.
Plasma level of breastfed infants from treated mothers with Mirtazapine are usually undetectable or very low.
Not significant clinically based side-effects in the infants both at short and long-term have been observed.
Isolated cases of galactorrhea have been reported.
The poor extrauterine adaptation that may appear in neonates just after birth when the pregnant woman has been treated with selective reuptake-inhibitors of Serotonin like Venlafaxine or Mirtazapine, is seen to be mild if the baby is breastfed.
Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.